{"id":"water-for-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypervolemia (fluid overload)"},{"rate":null,"effect":"Hyponatremia (low sodium)"},{"rate":null,"effect":"Local injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1098659","moleculeType":"Small molecule","molecularWeight":"18.02"},"_dailymed":{"setId":"d3a52eba-83d2-4fd1-8db5-dd04bcb1ba9d","title":"JYNNEOS (VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN) INJECTION, SUSPENSION JYNNEOS (VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION DILUENT COMPONENT (WATER FOR INJECTION) LIQUID [BAVARIAN NORDIC A/S]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Water for injection serves as a pharmaceutical vehicle and diluent for injectable medications. It is produced through distillation or reverse osmosis to ensure sterility and the absence of pyrogens (fever-inducing substances). It has no direct therapeutic mechanism but is essential for preparing injectable formulations and maintaining drug stability.","oneSentence":"Water for injection is a sterile, pyrogen-free solvent used to dilute or dissolve pharmaceutical substances for parenteral administration.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:06.634Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diluent for injectable pharmaceutical preparations"},{"name":"Vehicle for parenteral drug administration"}]},"trialDetails":[{"nctId":"NCT07183709","phase":"PHASE1","title":"Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-02-02","conditions":"COVID-19","enrollment":60},{"nctId":"NCT06565988","phase":"NA","title":"A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma","status":"COMPLETED","sponsor":"Bohus Biotech AB","startDate":"2024-09-02","conditions":"Midface Volume Deficit","enrollment":111},{"nctId":"NCT05024214","phase":"PHASE1, PHASE2","title":"Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors","status":"RECRUITING","sponsor":"3D Medicines (Sichuan) Co., Ltd.","startDate":"2021-11-15","conditions":"Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma","enrollment":170},{"nctId":"NCT05447559","phase":"PHASE4","title":"Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study","status":"RECRUITING","sponsor":"Monash University","startDate":"2023-02-07","conditions":"Surgical Site Infection","enrollment":9180},{"nctId":"NCT07491133","phase":"NA","title":"Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2026-03","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT02165410","phase":"NA","title":"MRI Study of Cerebral Blood Flow in Development Disorders in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-11-13","conditions":"Autism","enrollment":115},{"nctId":"NCT06692959","phase":"PHASE2","title":"A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer","status":"RECRUITING","sponsor":"University of Southampton","startDate":"2025-06-16","conditions":"Colorectal Cancer","enrollment":44},{"nctId":"NCT07485543","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-03","conditions":"Cystic Fibrosis","enrollment":24},{"nctId":"NCT05681884","phase":"PHASE2","title":"Safety and Efficacy of Faricimab in Patients With NPDR","status":"COMPLETED","sponsor":"Greater Houston Retina Research","startDate":"2023-05-16","conditions":"Non-Proliferative Diabetic Retinopathy","enrollment":179},{"nctId":"NCT06465108","phase":"PHASE2","title":"Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism","status":"COMPLETED","sponsor":"MBX Biosciences","startDate":"2024-08-08","conditions":"Hypoparathyroidism","enrollment":64},{"nctId":"NCT05608681","phase":"PHASE1, PHASE2","title":"A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).","status":"RECRUITING","sponsor":"Eupraxia Pharmaceuticals Inc.","startDate":"2023-03-31","conditions":"Eosinophilic Esophagitis","enrollment":117},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":"HIV Infections","enrollment":631},{"nctId":"NCT02598219","phase":"PHASE3","title":"Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2015-11","conditions":"Non Endometrioid Carcinoma, Endometrioid Carcinoma","enrollment":262},{"nctId":"NCT07474350","phase":"NA","title":"Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2023-09-01","conditions":"Labour Duration, Primigravida","enrollment":165},{"nctId":"NCT06568627","phase":"PHASE3","title":"A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)","status":"RECRUITING","sponsor":"MediWound Ltd","startDate":"2025-06-01","conditions":"Venous Leg Ulcer (VLU)","enrollment":216},{"nctId":"NCT00820820","phase":"NA","title":"IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2009-01-09","conditions":"Atopic Dermatitis","enrollment":20},{"nctId":"NCT06252493","phase":"","title":"Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-19","conditions":"Crohn Disease","enrollment":25},{"nctId":"NCT07465601","phase":"NA","title":"Daily Activity and Clinical Outcome Measurement of Arthrosamid® Administration in Symptomatic Knee Osteoarthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medisch Centrum Latem","startDate":"2024-07-25","conditions":"Knee Osteoarthristis","enrollment":29},{"nctId":"NCT07386327","phase":"NA","title":"Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes","status":"RECRUITING","sponsor":"Burçin Alaçam, MD","startDate":"2026-03-09","conditions":"Infraclavicular Brachial Plexus Block, Dextrose, Bupivacaine","enrollment":90},{"nctId":"NCT06617897","phase":"PHASE3","title":"Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2024-10-01","conditions":"Acquired Fibrinogen Deficiency","enrollment":90},{"nctId":"NCT05845749","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-09-25","conditions":"MPS IVA, MPS VI","enrollment":6},{"nctId":"NCT07448844","phase":"PHASE4","title":"Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2026-02-20","conditions":"Viral Wart, Plantar Wart, Common Warts (Verruca Vulgaris)","enrollment":40},{"nctId":"NCT07195331","phase":"PHASE4","title":"Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic Cholecystectomy.","status":"RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-02-26","conditions":"Laparoscopic Cholecystectomy Surgery","enrollment":122},{"nctId":"NCT04083235","phase":"PHASE3","title":"A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment","status":"COMPLETED","sponsor":"Ipsen","startDate":"2020-02-11","conditions":"Metastatic Adenocarcinoma of the Pancreas","enrollment":770},{"nctId":"NCT04723810","phase":"PHASE1, PHASE2","title":"TumorGlow Intraoperative Molecular Imaging (IMI)","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-08-14","conditions":"Tumor, Solid","enrollment":500},{"nctId":"NCT07450430","phase":"PHASE3","title":"Optimal Timing of Ketamine Initiation for SCD Pain","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-02","conditions":"Sickle Cell Disease, Sickle Cell Crisis","enrollment":90},{"nctId":"NCT07453433","phase":"","title":"Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study","status":"COMPLETED","sponsor":"Shanghai East Hospital","startDate":"2019-01-01","conditions":"Endoscopic Resection, Early Gastric Cancer","enrollment":548},{"nctId":"NCT07283094","phase":"PHASE1","title":"FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02-03","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":33},{"nctId":"NCT06428461","phase":"NA","title":"Evaluation of Supraclavicular Brachial Plexus Blocks at Various Volumes: Impact on Optic Nerve Sheath Diameter","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2024-05-20","conditions":"Upper Limb Injury, Intracranial Pressure Increase","enrollment":64},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT06813339","phase":"EARLY_PHASE1","title":"Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients","status":"RECRUITING","sponsor":"Cyclarity Therapeutics, Inc.","startDate":"2025-02-25","conditions":"Atherosclerotic Cardiovascular Disease, Acute Coronary Syndromes","enrollment":84},{"nctId":"NCT05997264","phase":"PHASE2","title":"Anthrax AV7909 Boost Evaluation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2023-12-05","conditions":"Anthrax","enrollment":220},{"nctId":"NCT07428538","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2026-01-29","conditions":"Hepatitis","enrollment":350},{"nctId":"NCT06782542","phase":"PHASE2","title":"Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy","status":"RECRUITING","sponsor":"Justin Watts, MD","startDate":"2026-05-01","conditions":"Acute Myeloid Leukemia, IDH1 Mutation","enrollment":16},{"nctId":"NCT06597006","phase":"PHASE3","title":"Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-28","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":9},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT07416227","phase":"NA","title":"Comparison Between Water Vapor Thermal Therapy and Prostatic Artery Embolization in Treatment of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-10-01","conditions":"Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms","enrollment":30},{"nctId":"NCT06009627","phase":"PHASE2, PHASE3","title":"Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2023-04-11","conditions":"Breast Cancer","enrollment":119},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT07198022","phase":"PHASE4","title":"Cryotherapy as a Topical Anesthetic in Healthy Children","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2025-09-01","conditions":"Healthy, Topical Anesthesia, Pediatric Dentistry","enrollment":100},{"nctId":"NCT07391514","phase":"","title":"Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2024-04-01","conditions":"Papillary Thyroid Carcinoma","enrollment":131},{"nctId":"NCT04743661","phase":"PHASE2","title":"131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pediatric Brain Tumor Consortium","startDate":"2022-04-04","conditions":"Recurrent Medulloblastoma, Recurrent Ependymoma","enrollment":62},{"nctId":"NCT07382596","phase":"PHASE4","title":"Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD","status":"NOT_YET_RECRUITING","sponsor":"Dr. Dean Reeves Clinic","startDate":"2026-03-01","conditions":"PTSD","enrollment":50},{"nctId":"NCT07386938","phase":"PHASE3","title":"A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"R-Pharm","startDate":"2024-08-09","conditions":"Locally Advanced Breast Cancer, Metastatic Breast Cancer","enrollment":246},{"nctId":"NCT05500417","phase":"PHASE1","title":"Safety and Immunogenicity of CJCV2 With and Without ALFQ","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-09-13","conditions":"Campylobacter Infection","enrollment":59},{"nctId":"NCT06321965","phase":"NA","title":"Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-07-24","conditions":"Spinal Muscular Atrophy","enrollment":60},{"nctId":"NCT07378904","phase":"NA","title":"Sterile Water Injection vs Morphine for Renal Colic","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Tunis El Manar","startDate":"2026-01-20","conditions":"Renal Colic, Urolithiasis","enrollment":150},{"nctId":"NCT04607408","phase":"PHASE1","title":"Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2020-11-10","conditions":"HIV Infections","enrollment":38},{"nctId":"NCT07377253","phase":"PHASE1","title":"First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.","status":"NOT_YET_RECRUITING","sponsor":"Giuseppe Pantaleo","startDate":"2026-01-01","conditions":"The Tick-borne Encephalitis Virus (TBEV)","enrollment":18},{"nctId":"NCT07373301","phase":"PHASE2","title":"Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia","status":"NOT_YET_RECRUITING","sponsor":"Malaria Vaccine and Drug Development Center","startDate":"2026-01-19","conditions":"Plasmodium Vivax Malaria, Plasmodium Vivax Infection, Malaria Prevention","enrollment":72},{"nctId":"NCT05092386","phase":"PHASE1","title":"Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine","status":"COMPLETED","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2023-01-03","conditions":"Pneumococcal Infections","enrollment":310},{"nctId":"NCT07374341","phase":"NA","title":"The Effectiveness of Guided Botulinum Toxin \"A\" Injection to the Masticatory Muscles in the Management of Condylar and Subcondylar Fractures","status":"RECRUITING","sponsor":"Pakinam Gheeta","startDate":"2025-04-10","conditions":"Condylar Fractures, Subcondylar Fracture","enrollment":16},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT07267013","phase":"PHASE2","title":"Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)","status":"NOT_YET_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-30","conditions":"Aortic Surgery, Extracorporeal Circulation","enrollment":25},{"nctId":"NCT06377956","phase":"","title":"The Associations Between Gut Length, Gut Microbiota and Food Assimilation","status":"COMPLETED","sponsor":"Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences","startDate":"2024-05-15","conditions":"Healthy Nutrition, Food Preferences, Metabolic Syndrome, Protection Against","enrollment":42},{"nctId":"NCT07205744","phase":"PHASE4","title":"Post-Menopause Skin Rejuvenation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erevna Innovations Inc.","startDate":"2025-08-14","conditions":"Aesthetic, Menopause, Post-menopause","enrollment":50},{"nctId":"NCT07324005","phase":"NA","title":"Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hydrodissection for Carpal Tunnel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Shin Kong Wu Ho-Su Memorial Hospital","startDate":"2026-01-01","conditions":"Carpal Tunnel Syndrome, Dextrose, Carpal Tunnel Release","enrollment":102},{"nctId":"NCT07351383","phase":"PHASE3","title":"Topical Cryoanesthesia Versus Benzocaine in Pediatric Dentistry","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2025-06-15","conditions":"Local Anesthetic Infiltration, Topical Anesthesia, Pain Perception","enrollment":28},{"nctId":"NCT06954441","phase":"PHASE3","title":"V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency","status":"RECRUITING","sponsor":"On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.","startDate":"2025-08-15","conditions":"Immunodeficiencies, Primary Immunodeficiencies (PID), Agammaglobulinemia","enrollment":50},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT05002998","phase":"PHASE4","title":"TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study","status":"COMPLETED","sponsor":"Amgen","startDate":"2021-09-16","conditions":"Thyroid Eye Disease","enrollment":313},{"nctId":"NCT05845398","phase":"PHASE1","title":"Phase 1b Study of DCR-AUD in Healthy Volunteers","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2023-01-29","conditions":"Alcohol Use Disorder","enrollment":16},{"nctId":"NCT07341360","phase":"EARLY_PHASE1","title":"Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2025-10-13","conditions":"Pseudomyxoma Peritonei","enrollment":10},{"nctId":"NCT04659863","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-02-16","conditions":"Familial Hypercholesterolemia - Homozygous","enrollment":13},{"nctId":"NCT06580678","phase":"PHASE2","title":"A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries","status":"COMPLETED","sponsor":"Byoung-Moo Seo","startDate":"2024-11-06","conditions":"Dentin Caries","enrollment":12},{"nctId":"NCT05569759","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)","status":"COMPLETED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-05-23","conditions":"Autoimmune Hepatitis","enrollment":24},{"nctId":"NCT06464939","phase":"PHASE2","title":"Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity","status":"COMPLETED","sponsor":"HysensBio Co., Ltd","startDate":"2024-10-08","conditions":"Dentin Hypersensitivity","enrollment":120},{"nctId":"NCT04652726","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-01-27","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":141},{"nctId":"NCT07321847","phase":"PHASE2, PHASE3","title":"Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases","status":"NOT_YET_RECRUITING","sponsor":"Immunophotonics, Inc.","startDate":"2026-05","conditions":"Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer","enrollment":717},{"nctId":"NCT05184842","phase":"PHASE2","title":"Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2022-03-23","conditions":"Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":91},{"nctId":"NCT05428007","phase":"PHASE2","title":"Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-02-02","conditions":"Melanoma, Unresectable Melanoma","enrollment":105},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":618},{"nctId":"NCT05454475","phase":"","title":"Effect of Different Water Injection Temperatures on the Safety and Comfort of Patients Undergoing Ultrasound Endoscopy of Small Probes Under Intravenous Anesthesia","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2022-06-14","conditions":"Small Probe Ultrasound Endoscopy, The Water Temperature","enrollment":270},{"nctId":"NCT05182125","phase":"PHASE1","title":"Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2021-11-25","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT03879447","phase":"","title":"Effectiveness and Safety of Korean Medicine for Low Back Pain or Sciatica Due to Lumbar Stenosis/Spondylolisthesis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaseng Medical Foundation","startDate":"2019-06-24","conditions":"Lumbar Spinal Stenosis, Lumbar Spondylolisthesis, Low Back Pain","enrollment":110},{"nctId":"NCT06770491","phase":"PHASE1","title":"A Phase 1 Study of Y-3 in US Healthy Volunteers.","status":"COMPLETED","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2025-02-04","conditions":"Safety, Tolerability, Pharmacokinetic Study in Healthy Volunteers","enrollment":20},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT06825494","phase":"PHASE1, PHASE2","title":"Clinical Studies for the Treatment of Advanced Solid Tumors","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2025-04-08","conditions":"Advanced Solid Tumor","enrollment":194},{"nctId":"NCT06845358","phase":"PHASE1","title":"Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-11-26","conditions":"Tuberculosis","enrollment":""},{"nctId":"NCT03959098","phase":"","title":"Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaseng Medical Foundation","startDate":"2019-06-24","conditions":"Neck Pain, Cervical Radiculopathy, Intervertebral Disc Displacement","enrollment":120},{"nctId":"NCT07201688","phase":"PHASE3","title":"Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.","status":"RECRUITING","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-30","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT06630884","phase":"PHASE1","title":"Inflammatory Challenge and Fear","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-03-28","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":288},{"nctId":"NCT06542198","phase":"NA","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-09-10","conditions":"Polyuria-polydipsia Syndrome, Arginine Vasopressin Deficiency, Primary Polydipsia","enrollment":42},{"nctId":"NCT07057050","phase":"NA","title":"Constraint-induced Movement Therapy Versus Task-oriented Training On Upper Extremity Function Post-Botox Injection in Stroke Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-06-30","conditions":"Constraint Induced Movement Therapy, Task Oriented Training, Botox Injection","enrollment":51},{"nctId":"NCT06107673","phase":"PHASE2","title":"Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）","status":"RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2023-09-30","conditions":"Breast Cancer","enrollment":144},{"nctId":"NCT03705234","phase":"PHASE3","title":"A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2018-10-30","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":16124},{"nctId":"NCT06022263","phase":"PHASE1","title":"STA363 in the Treatment of Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Stayble Therapeutics","startDate":"2023-07-25","conditions":"Lumbar Disc Herniation","enrollment":25},{"nctId":"NCT06341114","phase":"PHASE1, PHASE2","title":"A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bio-Thera Solutions","startDate":"2024-04-12","conditions":"Advanced Solid Tumors","enrollment":112},{"nctId":"NCT04069299","phase":"","title":"Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-09-25","conditions":"Neuroendocrine Carcinoma","enrollment":30},{"nctId":"NCT06520163","phase":"PHASE3","title":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2024-08-01","conditions":"Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization","enrollment":99},{"nctId":"NCT06390956","phase":"PHASE2","title":"Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2025-02-20","conditions":"Marginal Zone Lymphoma","enrollment":23},{"nctId":"NCT03039673","phase":"PHASE2","title":"MIROCALS: Modifying Immune Response and OutComes in ALS","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-06-19","conditions":"Amyotrophic Lateral Sclerosis","enrollment":304},{"nctId":"NCT06221371","phase":"PHASE3","title":"Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-01-25","conditions":"Ischemic Stroke, Acute, Thrombolysis, Endovascular Treatment","enrollment":391},{"nctId":"NCT07251608","phase":"PHASE1","title":"Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus","status":"RECRUITING","sponsor":"ChromaDex, Inc.","startDate":"2025-10-01","conditions":"Healthy Volunteer, Fatigue","enrollment":40},{"nctId":"NCT06948045","phase":"NA","title":"RESTRUCTURING THE MANDIBULAR ANGLE IN FACIAL AGING: A NOVEL TECNIQUE USING POLY-L-LACTIC ACID","status":"NOT_YET_RECRUITING","sponsor":"Doris Hexsel","startDate":"2026-02-01","conditions":"Skin Laxity, Facial Aging","enrollment":46},{"nctId":"NCT07244471","phase":"","title":"Water-injecting Endoscopic Submucosal Dissection for Early Gastric Cancer: a Retrospective Cohort Study","status":"COMPLETED","sponsor":"Shanghai East Hospital","startDate":"2019-01-01","conditions":"Endoscopic Resection, Early Gastric Cancer","enrollment":548},{"nctId":"NCT06597019","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-12-09","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":51},{"nctId":"NCT01588171","phase":"NA","title":"Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-05","conditions":"Venous Thromboembolic Diseases","enrollment":7020},{"nctId":"NCT04644237","phase":"PHASE2","title":"Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2021-03-19","conditions":"Non-Small Cell Lung Cancer","enrollment":152},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188}],"_emaApprovals":[],"_faersSignals":[{"count":108,"reaction":"MALAISE"},{"count":88,"reaction":"DEATH"},{"count":86,"reaction":"NO ADVERSE EVENT"},{"count":86,"reaction":"PYREXIA"},{"count":85,"reaction":"DYSPNOEA"},{"count":82,"reaction":"NAUSEA"},{"count":75,"reaction":"VOMITING"},{"count":71,"reaction":"FATIGUE"},{"count":67,"reaction":"ABDOMINAL PAIN"},{"count":67,"reaction":"OFF LABEL USE"}],"_approvalHistory":[],"publicationCount":442,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Juhel water for injection","Aqua ad iniectabilia","Sterile Water For Injection","Sterile water"],"phase":"marketed","status":"active","brandName":"Water for injection","genericName":"Water for injection","companyName":"Ahmadu Bello University Teaching Hospital","companyId":"ahmadu-bello-university-teaching-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Water for injection is a sterile, pyrogen-free solvent used to dilute or dissolve pharmaceutical substances for parenteral administration. Used for Diluent for injectable pharmaceutical preparations, Vehicle for parenteral drug administration.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}